The store will not work correctly when cookies are disabled.
4-[4-(benzoylamino)benzoyl]benzoic acid
ID: ALA201651
Chembl Id: CHEMBL201651
PubChem CID: 11681722
Max Phase: Preclinical
Molecular Formula: C21H15NO4
Molecular Weight: 345.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: 4-[4-(Benzoylamino)Benzoyl]Benzoic Acid | 4-[4-(benzoylamino)benzoyl]benzoic acid|CHEMBL201651|PD182003
Canonical SMILES: O=C(O)c1ccc(C(=O)c2ccc(NC(=O)c3ccccc3)cc2)cc1
Standard InChI: InChI=1S/C21H15NO4/c23-19(14-6-8-17(9-7-14)21(25)26)15-10-12-18(13-11-15)22-20(24)16-4-2-1-3-5-16/h1-13H,(H,22,24)(H,25,26)
Standard InChI Key: FKMULXSKUTZDBD-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 345.35 | Molecular Weight (Monoisotopic): 345.1001 | AlogP: 3.87 | #Rotatable Bonds: 5 |
Polar Surface Area: 83.47 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.76 | CX Basic pKa: ┄ | CX LogP: 4.18 | CX LogD: 0.90 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.69 | Np Likeness Score: -0.73 |
References
1. Salem OI, Frotscher M, Scherer C, Neugebauer A, Biemel K, Streiber M, Maas R, Hartmann RW.. (2006) Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids., 49 (2): [PMID:16420060] [10.1021/jm050728w] |